Skip to Content

Wednesday, October 28th, 2020
Home / 2019 / December / 05

Daily Archives: December 5, 2019

The European Commission Approves Astellas’ XOSPATA® for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation Detected by Validated Tests, including the Invivoscribe LeukoStrat CDx FLT3 Mutation Assay

SAN DIEGO, Dec. 05, 2019 (GLOBE NEWSWIRE) — For twenty-five years, Invivoscribe has improved the quality of hea…